A world-renowned child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators, "The New York Times" reported June 8.
By failing to report income, the psychiatrist, Joseph Biederman, M.D., and a colleague in the psychiatry department at Harvard Medical School, Timothy Wilens, M.D., may have violated federal and university research rules designed to police potential conflicts of interest, according to Sen. ...